# Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab

> clinical trial · VERIFIED · 2026-08-11

Status: ENROLLING_BY_INVITATION · Sponsor: AstraZeneca · Condition: Cancer

- Company: AstraZeneca
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05303532

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.